search
Back to results

Short-term Clinical Performance of Multifocal Soft Contact Lens

Primary Purpose

Myopia

Status
Active
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
MiSight mutifocal soft contact lens
Proclear 1 Day soft contact lens
Sponsored by
Zhongshan Ophthalmic Center, Sun Yat-sen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

8 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • • Prior to being considered eligible to participate in this study, each subject MUST:

    1. Be between 8 and 12 years of age inclusive at the baseline examination.
    2. Have:

      1. read the Informed Assent,
      2. been given an explanation of the Informed Assent,
      3. indicated an understanding of the Informed Assent and
      4. signed the Informed Assent Form.
    3. Have their parent or legal guardian:

      1. read the Informed Consent,
      2. been given an explanation of the Informed Consent,
      3. indicated an understanding of the Informed Consent and
      4. signed the Informed Consent Form.
    4. Along with their parent or guardian, be capable of comprehending the nature of the study and be willing and able to adhere to the instructions set forth in this protocol.
    5. Along with their parent or guardian, agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study.
    6. Agree to wear the assigned contact lenses for the duration of the 1-month study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.)
    7. Meet the following refractive criteria determined by cycloplegic autorefraction at baseline:

      1. Spherical refractive error: between -0.75 and -4.00 D inclusive,
      2. Astigmatism: ≤-0.75 D,
      3. Anisometropia: ≤1.50D,
    8. Best-corrected visual acuity :≥0.8.

Exclusion Criteria:

  • • Subjects may not be considered eligible if ANY of the following apply:

    1. Subject has regular use of ocular medications.
    2. Any systemic disease which is not suggested to wear contact lens or current use of systemic medications which may significantly affect contact lens wear, visual function, or refractive state.
    3. A history of ocular trauma or ocular surgery in the last 8 weeks.
    4. Subject has worn rigid gas permeable contact lenses in the last 6 weeks, including orthokeratology lenses.
    5. Abnormal secretion or excretion of tear fluid, infection of the tear ducts, or other recurrent ocular infections.
    6. A known allergy to fluorescein, benoxinate, proparacaine, or tropicamide.
    7. Keratoconus or an irregular cornea.
    8. Subjects who have been in a special environment such as dryness, serious dust, or volatile chemicals for a long time affect the wear of contact lenses.
    9. Strabismus, amblyopia patients, only one eye meets the admission conditions.
    10. Subjects have received any myopia control treatment.
    11. Subject is currently an active participant in another clinical study.

Sites / Locations

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Experimental Group

Arm Description

one group for contact lens

Outcomes

Primary Outcome Measures

Change in the contrast sensitivity visual function (CSF) relative to baseline at 1 month

Secondary Outcome Measures

Patients' subjective acceptability to multifocal soft contact lens
The patients will be asked to complete questionnaires at each visit regarding vision, lens comfort, the difficulty of lens insert and removal, etc. of the multifocal contact lens.
Doctors' clinical evaluation to multifocal soft contact lens
The doctors will be asked to complete questionnaires regarding the difficulty of fitting procedure and general impression of the multifocal contact lens.
Change in the contact lens corrected visual acuity relative to baseline
Patients will wear contact lens when they are tested

Full Information

First Posted
February 28, 2022
Last Updated
December 26, 2022
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
search

1. Study Identification

Unique Protocol Identification Number
NCT05273606
Brief Title
Short-term Clinical Performance of Multifocal Soft Contact Lens
Official Title
A Clinical Study of Short-term Clinical Performance of Multifocal Soft Contact Lens
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 16, 2022 (Actual)
Primary Completion Date
December 13, 2022 (Actual)
Study Completion Date
December 16, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study is aimed to observe the short-term clinical performance of MiSight™ multifocal soft contact lens compared with Proclear™ 1day, including objective examination, subjective acceptability of wearers, and doctors' evaluation of the clinical manifestations of lenses.
Detailed Description
Compared with Proclear™ 1day, observe the short-term clinical performance of MiSight™ multifocal soft contact lens including objective examination, subjective acceptability of wearers, and doctors' evaluation of the clinical manifestations of lenses in 1 month.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental Group
Arm Type
Experimental
Arm Description
one group for contact lens
Intervention Type
Device
Intervention Name(s)
MiSight mutifocal soft contact lens
Intervention Description
Subjects will wear MiSight™ multifocal soft contact lenses for 1 month.
Intervention Type
Device
Intervention Name(s)
Proclear 1 Day soft contact lens
Intervention Description
Proclear™ 1 Day soft contact lens will be worn for baseline evaluation.
Primary Outcome Measure Information:
Title
Change in the contrast sensitivity visual function (CSF) relative to baseline at 1 month
Time Frame
Proclear baseline;VMisight baseline; 1 week; 1month
Secondary Outcome Measure Information:
Title
Patients' subjective acceptability to multifocal soft contact lens
Description
The patients will be asked to complete questionnaires at each visit regarding vision, lens comfort, the difficulty of lens insert and removal, etc. of the multifocal contact lens.
Time Frame
Proclear baseline; Misight baseline; 1 week; 1month
Title
Doctors' clinical evaluation to multifocal soft contact lens
Description
The doctors will be asked to complete questionnaires regarding the difficulty of fitting procedure and general impression of the multifocal contact lens.
Time Frame
Proclear baseline; Misight baseline; 1 week; 1month
Title
Change in the contact lens corrected visual acuity relative to baseline
Description
Patients will wear contact lens when they are tested
Time Frame
Proclear baseline;Misight baseline;1 week;1month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • Prior to being considered eligible to participate in this study, each subject MUST: Be between 8 and 12 years of age inclusive at the baseline examination. Have: read the Informed Assent, been given an explanation of the Informed Assent, indicated an understanding of the Informed Assent and signed the Informed Assent Form. Have their parent or legal guardian: read the Informed Consent, been given an explanation of the Informed Consent, indicated an understanding of the Informed Consent and signed the Informed Consent Form. Along with their parent or guardian, be capable of comprehending the nature of the study and be willing and able to adhere to the instructions set forth in this protocol. Along with their parent or guardian, agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study. Agree to wear the assigned contact lenses for the duration of the 1-month study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.) Meet the following refractive criteria determined by cycloplegic autorefraction at baseline: Spherical refractive error: between -0.75 and -4.00 D inclusive, Astigmatism: ≤-0.75 D, Anisometropia: ≤1.50D, Best-corrected visual acuity :≥0.8. Exclusion Criteria: • Subjects may not be considered eligible if ANY of the following apply: Subject has regular use of ocular medications. Any systemic disease which is not suggested to wear contact lens or current use of systemic medications which may significantly affect contact lens wear, visual function, or refractive state. A history of ocular trauma or ocular surgery in the last 8 weeks. Subject has worn rigid gas permeable contact lenses in the last 6 weeks, including orthokeratology lenses. Abnormal secretion or excretion of tear fluid, infection of the tear ducts, or other recurrent ocular infections. A known allergy to fluorescein, benoxinate, proparacaine, or tropicamide. Keratoconus or an irregular cornea. Subjects who have been in a special environment such as dryness, serious dust, or volatile chemicals for a long time affect the wear of contact lenses. Strabismus, amblyopia patients, only one eye meets the admission conditions. Subjects have received any myopia control treatment. Subject is currently an active participant in another clinical study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xiao Yang, PhD
Organizational Affiliation
Zhongshan Ophthalmic Center, Sun Yat-sen University
Official's Role
Study Chair
Facility Information:
Facility Name
Zhongshan Ophthalmic Center, Sun Yat-sen University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510060
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Short-term Clinical Performance of Multifocal Soft Contact Lens

We'll reach out to this number within 24 hrs